Today Eric Hanson, the Executive Chairman and Chief Strategy officer of Klin Groupe, the parent company of Hammer + Sickle Cigars issued a statement on the FDA.
“Hammer + Sickle Cigars remains fully committed to our cigar business in the United States. We will be filing Substantial Equivalence for all of our blends available in the US marketplace. Through our deep experience in the highly regulated beverage alcohol space, we are organized and resourced to comply with the Substantial Equivalence filing processes, procedures and expenses. We expect Hammer + Sickle to be a strong partner in your humidor for many years to come.”
The Klin Groupe also sells Hammer + Sickle Vodka and other fine spirits.
